The Traderszone Network

Published in TZ Latest News 7 December, 2015 by The TZ Newswire Staff

Immune Design Highlights G100 Preclinical Data Demonstrating Direct and Abscopal Tumor Regression, Long-Term Response and Synergy With Checkpoint Blockade